Inventor
BRADLEY MICHAEL F
US21 patents
⚠️ This page may combine multiple inventors who share the name “BRADLEY MICHAEL F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
10 patentsUS7728143B2Jun 1, 2010
Salt and crystalline forms thereof of a drug
ABBOTT LAB13 citations92
US6716963B1Apr 6, 2004
Peptide antiangiogenic drugs
ABBOTT LAB15 citations83
US6774211B1Aug 10, 2004
Peptide antiangiogenic drugs
ABBOTT LAB10 citations73
US6777535B1Aug 17, 2004
N-alkylated peptides having antiangiogenic activity
ABBOTT LAB3 citations62
US7067490B2Jun 27, 2006
Hepta-, Octa-and nonapeptides having antiangiogenic activity
ABBOTT LAB1 citations52
US7001984B2Feb 21, 2006
Di-, tri-, and tetra-peptides having antiangiogenic activity
ABBOTT LAB1 citations52
US7592466B2Sep 22, 2009
Ureas having antiangiogenic activity
ABBOTT LAB0 citations41
US7169888B2Jan 30, 2007
Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
ABBOTT LAB0 citations41
US7122625B2Oct 17, 2006
Hexa-, hepta-, and octapeptides having antiangiogenic activity
ABBOTT LAB0 citations41
US7037897B2May 2, 2006
TRI-, TETRA-, and penta-peptides having antiangiogenic activity
ABBOTT LAB0 citations41
ABBVIE INC
4 patentsUS9539250B2Jan 10, 2017
Salt and crystalline forms thereof of a drug
ABBVIE INC3 citations84
US8969569B2Mar 3, 2015
Salt and crystalline forms thereof of a drug
ABBVIE INC5 citations84
US10329276B2Jun 25, 2019
Salt and crystalline forms thereof of a drug
ABBVIE INC1 citations73
US9873681B2Jan 23, 2018
Salt and crystalline forms thereof of a drug
ABBVIE INC1 citations62